state of the heart update - uk healthcare cecentral as… · •objective – explain how the gill...

15
State of the Heart Update: UK Gill Heart and Vascular Institute CV Academic Service Line Update Susan Smyth, MD, PhD Chief, Cardiovascular Medicine Director, UK Gill Heart and Vascular Institute

Upload: others

Post on 03-Oct-2020

2 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: State of the Heart Update - UK HealthCare CECentral AS… · •Objective – Explain how the Gill Heart and Vascular Institute is leading the fight against cardiovascular disease

State of the Heart Update: UK Gill Heart and Vascular Institute CV Academic Service Line Update

Susan Smyth, MD, PhD Chief, Cardiovascular Medicine

Director, UK Gill Heart and Vascular Institute

Page 2: State of the Heart Update - UK HealthCare CECentral AS… · •Objective – Explain how the Gill Heart and Vascular Institute is leading the fight against cardiovascular disease

• I have nothing to disclose

ECMO Transport Team

Disclosure

Page 3: State of the Heart Update - UK HealthCare CECentral AS… · •Objective – Explain how the Gill Heart and Vascular Institute is leading the fight against cardiovascular disease

• Objective – Explain how the Gill Heart and Vascular Institute is leading the

fight against cardiovascular disease and stroke in Kentucky through advancements in wellness, patient-centered care, research, education, and collaboration.

• Educational Need/Practice Gap/Outcomes – To inform our affiliate community of the advanced therapies and

burgeoning technologies offered at the University of Kentucky so that together, we can broaden access to advanced care for patients across the Commonwealth.

Presentation Overview

Page 4: State of the Heart Update - UK HealthCare CECentral AS… · •Objective – Explain how the Gill Heart and Vascular Institute is leading the fight against cardiovascular disease

Copyright © 2015 Deloitte Development LLC. All rights reserved.

UK Gill Heart and Vascular Institute The Gill Goal

Page 5: State of the Heart Update - UK HealthCare CECentral AS… · •Objective – Explain how the Gill Heart and Vascular Institute is leading the fight against cardiovascular disease

Our vision is to improve the nation’s heart health

Enable the education of all stakeholders

Leverage clinical innovation &

discovery research

Expand the GHVI Network

Develop a Gill standard

Create an integrated service line platform

• Our mission is to provide: – Seamless, high-quality, and comprehensive care

– Value to those we serve

– Cutting-edge innovation and discovery research

– Leadership in education

Page 6: State of the Heart Update - UK HealthCare CECentral AS… · •Objective – Explain how the Gill Heart and Vascular Institute is leading the fight against cardiovascular disease

• 400th Heart Transplantation – 1-year survival 98% – 3-year survival 91% – 34 VADs implanted in 2018 to date – Dual organ transplants

• ECMO Transport – Performed 91 runs in CY 2017 – Travel up to 4 hours – ELSO gold level Center of Excellence

ECMO Transport Team

Advancing Care for Heart Failure

Page 7: State of the Heart Update - UK HealthCare CECentral AS… · •Objective – Explain how the Gill Heart and Vascular Institute is leading the fight against cardiovascular disease

• Tremendous program growth (over 800 visits for 2018) • Patient support group established • Research protocols

KACH Director, Dr. Andrew Leventhal,

meets with Priscilla Riley, recipient of Sapien 3

transcatheter heart valve

KACH – Kentucky Adult Congenital Heart Program

Page 8: State of the Heart Update - UK HealthCare CECentral AS… · •Objective – Explain how the Gill Heart and Vascular Institute is leading the fight against cardiovascular disease

• Focus Areas – Microvascular Disease – Cardio-oncology – Cardiac and Pregnancy Disease – Prevention – Research

Whitney Stevenson

Women’s Heart Health

Volcano ComboMap testing identified coronary microvascular disease as the cause of sporadic chest pain and shortness of breath that plagued Whitney Stevenson for over seven years

Page 9: State of the Heart Update - UK HealthCare CECentral AS… · •Objective – Explain how the Gill Heart and Vascular Institute is leading the fight against cardiovascular disease

• Atrial Fibrillation Program • Cutting-edge Clinical Trials to improve qualify of life

– BeatHF Device Resets autonomic balance by carotid stimulation

– FIX-HF-5CA Device Improves heart contractility by increasing calcium

Electrophysiological Services – Changing Lives through Technology

Aaron Hesselson, MD Director of Electrophysiologic Services

Page 10: State of the Heart Update - UK HealthCare CECentral AS… · •Objective – Explain how the Gill Heart and Vascular Institute is leading the fight against cardiovascular disease

• Over 200% growth in procedures • Vascular Collaborative and Quality Initiative

• Supervised Exercise Program for patients with PAD

Vascular Surgery – Making Strides

Jacob Stone, MSEP, CSCS, Cardiopulmonary Rehab Program

Supervisor, and Dr. Nathan Orr present a webinar on supervised exercise therapy for patients with

peripheral arterial disease.

Page 11: State of the Heart Update - UK HealthCare CECentral AS… · •Objective – Explain how the Gill Heart and Vascular Institute is leading the fight against cardiovascular disease

• Over 700 procedures in 2017 • Developed quality improvement

plan and protocol to reduce variations in care

• Observed-to-expected mortality ratio of 0.66

• Participating in BPCI for CABG

CT Surgery – A Heartening Rise in Quality

Michael Sekela, MD, Surgical Director of Heart

Transplant Chief, CT Surgery

Page 12: State of the Heart Update - UK HealthCare CECentral AS… · •Objective – Explain how the Gill Heart and Vascular Institute is leading the fight against cardiovascular disease

OVERALL AMI performance composite

Defect-free care

98.8% 92.8% of our patients met eligible opportunities of performance measure opportunities – the US average for hospitals is 96.7%

of our patients received "perfect care" based upon eligibility for each performance measure – the US average for hospitals is 81.3%

STEMI Performance Composite 98.8%

Gill – by the Numbers

Page 13: State of the Heart Update - UK HealthCare CECentral AS… · •Objective – Explain how the Gill Heart and Vascular Institute is leading the fight against cardiovascular disease

• Precision Medicine and CV Genetics – Screening for syndromes – Genetic risk score (e.g. for CAD and AF) – Identify gene – environment interactions

• Virtual Heart Program – NIH funding

• Aortopathy Center – AHA funding • CV Biorepository – philanthropic funding

Innovation and Research

Page 14: State of the Heart Update - UK HealthCare CECentral AS… · •Objective – Explain how the Gill Heart and Vascular Institute is leading the fight against cardiovascular disease

• Developing a multicomponent, Multilevel Implementation Strategy for Syncope OptimalCare through Engagement

• Goal to increase adherence to guideline recommendations and reduce variations in care

• Collaboration between UK, Norton, Georgetown, ARH

Project MISSION

Partnership with Center for Health Services Research

Page 15: State of the Heart Update - UK HealthCare CECentral AS… · •Objective – Explain how the Gill Heart and Vascular Institute is leading the fight against cardiovascular disease

Questions? Thank you!